|
|
|
Study on factors affecting TB/HIV co-infection
in four counties of China |
| Shi-Ming CHENG MD1,Yu-Ji LAI MS1,Er-Yong LIU MS1,Lin ZHOU MD1,Xue-Jing WANG MS1,Qiu-Lan CHEN MS1,Dong-Ming LI MS2,Ning WANG MD2, |
| 1.National Center for
TB Control and Prevention, Chinese Center for Disease Control and
Prevention, Beijing 102206, China; 2.National Center for
AIDS/STD Control and Prevention, Chinese Center for Disease Control
and Prevention, Beijing 102206, China; |
|
|
|
|
Abstract The factors affecting case detection of tuberculosis (TB)/human immunodeficiency virus (HIV) co-infection cases were explored in order to provide evidence-based formulation of a TB/HIV co-infection control strategy in China. Four counties with different modes of HIV transmission and varying cooperation mechanisms between TB and HIV institutions were selected. HIV test among TB patients and TB examination among people living with HIV/acquired immunodeficiency syndrome (AIDS) were conducted. Patients also completed questionnaires on potential factors affecting TB/HIV co-infection. The results showed that 19 (1.7%) were HIV-positive among 1089 cases of people living with active TB who received HIV testing. Conversely, there were 126 (10%) cases of active TB among 1255 cases of people living with HIV/AIDS. Among the newly discovered 145 cases of TB/HIV co-infection, AIDS institutions found 86.9% of these co-infections and 14.1% came from TB institutes. In different registration categories, there were 31 (21.4%) cases of smear positive TB, 104 (71.7%) cases of smear negative TB, and extrapulmonary cases accounted for 10 (6.9%). Gender, occupation, marital status, ethnic group, education, HIV transmission route, CD4 level, and type of TB susceptible symptoms had significant effects on whether HIV/AIDS patients were co-infected with TB disease (P<0.01). Sex, age, ethnic group, occupation, and type of tuberculosis had no significant influence on whether TB patients had HIV infection. AIDS institutions could find more TB/HIV co-infection patients in comparison with TB institutions, particularly in patients with smear negative pulmonary tuberculosis and extrapulmonary tuberculosis. Therefore, a cooperation mechanism should be built up between TB and HIV control systems, and routine TB checks should be conducted for HIV/AIDS patients. In areas where sex or drug use is the major transmission mode of HIV infection, antiretroviral therapy should be expanded, treatment adherence should be improved and patients’ immunity level should be increased in order to decrease TB incidence. Cough and expectoration of more than two weeks, bloody sputum, and recurrent fevers could be revealing symptoms in TB screening of HIV/AIDS patients.
|
| Keywords
tuberculosis/acquired immunodeficiency syndrome
dual infection
prevention and control
case detection
impact factors
|
|
Issue Date: 05 June 2010
|
|
|
Guideline for ImplementingCollaborative TB and HIV Programme Activities. Geneva, World Health Organization, 2004
|
|
Tuberculosis and HIV: a frameworkto address TB/HIV co-infection in the Western Pacific Region. Geneva, World Health Organization, 2004
|
|
Lee W R. Clin Infect Dis, 1993, 17(suppl): 442–446
|
|
WHO. Global Tuberculosis Control: A short update to the 2009 report. World Health Organization, 2009
|
|
NCTB. 2008 TB surveillance report, China CDC
|
|
www.moh.gov.cn/publicfiles/business/htmlfiles/wsb/pwsyw/200911/44754.htm
|
|
Xie H A, Yang G T, Lin S X. Modern tuberculosis. Beijing: People’s Medical Publishing House, 2000, 431–444 (in Chinese)
|
|
Malkin J E, Prazuck T, Simonnet F, Yameogo M, Rochereau A, Ayeroue J, Masson D, Lafaix C. Tuberculosis and human immunodeficiency virus infection in west Burkina Faso: clinicalpresentation and clinical evolution. Int J Tuberc Lung Dis, 1997, 1(1): 68–74
|
|
Fishman A P. Fishman’s pulmonary diseases and disorders. New York, NY: McGraw Hill Companies, 1998, 2103–2120
|
|
Perenboom R M, Richter C, Swai A B, Kitinya J, Mtoni I, Chande H, Kazema R R. Clinical features of HIV seropositive and HIV seronegative patientswith tuberculous lymphadenitis in Dar es Salaam. Tuber Lung Dis, 1995, 76(5): 401–406
doi: 10.1016/0962-8479(95)90005-5
|
|
Goletti D, Weissman D, Jackson R W, Graham N M, Vlahov D, Klein R S, Munsiff S S, Ortona L, Cauda R, Fauci A S. Effect of Mycobacterium tuberculosis on HIV replication.Role of immune activation. J Immunol, 1996, 157(3): 1271–1278
|
|
Toossi Z. Virological and immunological impact of tuberculosison human immunodeficiency virus type 1 disease. J Infect Dis, 2003, 188(8): 1146–1155
doi: 10.1086/378676
|
|
Williams B G, Dye C. Antiretroviral drugs for tuberculosis control in the era of HIV/AIDS. Science, 2003, 301(5639): 1535–1537 doi:10.1126/science.1086845 PMID:12920302
doi: 10.1126/science.1086845
|
|
www.infectcma.org.cn/news.php?cate=175521&id=7469
|
|
Zhang F J, Dou Z H, Ma Y, Zhao Y, Liu Z F, Bulterys M, Chen R Y. Five-year outcomes of theChina national free antiretroviral treatment program. Ann Intern Med, 2009, 151(4): 241–251, W-52
|
|
Ma Y, Zhang F J, Zhao Y, Zang C P, Zhao D C, Dou Z H, Yu L, Fang H, Zhu T F, Chen R Y. Cohort profile: The Chinesenational free antiretroviral treatment cohort. Int J Epidemiol, 2009, doi:10.1093/ije/dyp233
doi: 10.1093/ije/dyp233
|
|
Wang X W. Progress of TB/HIV co-infection researches. Zhongguo Redaibing Xue, 2005, 5(6): 1331–1332 (in Chinese)
|
|
Li C M. TB and HIV. Linchuang Feike Zazhi, 2002, 7(1): 37 (in Chinese)
|
|
Wang Z X. TB/HIV prevention and Control. Zhongguo Fanglao Zazhi, 1996, 16(1): 31 (in Chinese)
|
|
Zhang H W. TB and HIV. Zhongguo Fanglao Zazhi, 2005, 27(9): 100–101 (in Chinese)
|
|
Cheng Y P, Hua C. HIV/AIDS prevalence in China and its impact factors. Chin J Misdiagnostics, 2004, 4(5): 696–697 (in Chinese)
|
|
Wang N. HIV epidemic in China and the world: current situationand challenges. Keji Daobao, 2005, 23(7): 4–8 (in Chinese)
|
|
UNAIDS. Report on the global AIDS epidemic, UNAIDS, 2008
|
|
Liu J, Huang H L, Yang X L. TB/HIV prevalence and its control measuresin China. Jibing Kongzhi Zazhi, 2007, 11(2): 200–202 (in Chinese)
|
|
Liu F Y, Wang X W, Xu G B, Dong B Q, Cui Z Z, Liang X Y. Characteristic of TB/HIV co-infection population in Guangxi. ZhongGuo Jiangkang Jiaoyu, 2008, 24(6): 439–440 (in Chinese)
|
|
www.aidsmap.com/en/news/E0BEEE63-DE8A-49AA-9B63-252765244528.asp
|
|
Kimmerling M E. Active TB case finding within a continuum of care package:linking TB and HIV services through voluntary counseling and testingcenters in Battambang province, Cambodia. In: Proceedings of 38th World Lung Health Conference, 2007
|
|
Cain K. Developing a clinical algorithm to diagnose TB in HIV-infectedpersons in SE Asia. In: Proceedings of 38th World Lung Health Conference, 2007
|
|
Demissie M D. Testing different TB screening strategies: intensifiedTB case finding among HIV-infected personnel at a voluntary counselingand testing centre, Addis Ababa, Ethiopia. In: Proceedings of 38th World Lung Health Conference, 2007
|
|
Odhiambo J. Implementing intensified TB case finding guidelines atcountry level: the Kenya example. In: Proceedings of 38th Union World Conference on Lung Health, 2007
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
| |
Shared |
|
|
|
|
| |
Discussed |
|
|
|
|
